Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer
Chunni Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Han(Shandong University), Lin Wang(Second Hospital of Tianjin Medical University), Ning Lü(The University of Texas MD Anderson Cancer Center), Weiwei Fu(Shandong University), Weiwei Tan(Shandong University), Bo Su(Shandong University), Xiaoqing Yang(Nantong University), Jingjing Song(Qingdao University)
Cited by 54
Related Papers
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
|The Lancet Oncology|2020|401
Use of Mobile Health Applications for Health-Seeking Behavior Among US Adults
|Journal of Medical Systems|2016|220
Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma
|Annals of Oncology|2013|126
High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation
|Journal of Experimental & Clinical Cancer Research|2017|94